Brainstorm Cell Therapeutics Inc. (BCLI): Price and Financial Metrics
BCLI Price/Volume Stats
| Current price | $1.13 | 52-week high | $8.09 |
| Prev. close | $1.12 | 52-week low | $0.72 |
| Day low | $1.11 | Volume | 199,800 |
| Day high | $1.15 | Avg. volume | 753,702 |
| 50-day MA | $1.11 | Dividend yield | N/A |
| 200-day MA | $2.01 | Market Cap | 8.97M |
BCLI Stock Price Chart Interactive Chart >
Brainstorm Cell Therapeutics Inc. (BCLI) Company Bio
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. The company was founded in 2000 and is based in Hackensack, New Jersey.
BCLI Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BCLI Price Returns
| 1-mo | -6.61% |
| 3-mo | -29.38% |
| 6-mo | -28.93% |
| 1-year | -81.76% |
| 3-year | -97.46% |
| 5-year | -99.17% |
| YTD | -50.22% |
| 2024 | -44.57% |
| 2023 | -83.35% |
| 2022 | -59.00% |
| 2021 | -11.60% |
| 2020 | 5.72% |